Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance

Meridian Bioscience (VIVO) Misses Q3 EPS by 1c

July 28, 2016 9:16 AM EDT

Meridian Bioscience (NASDAQ: VIVO) reported Q3 EPS of $0.21, $0.01 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $50.7 million versus the consensus estimate of $52.85 million.

updated its fiscal 2016 guidance of per share diluted earnings between $0.86 and $0.90 on a non-GAAP... More